Gnomx: area of interest no. 23 host-based diagnostics. The overall goal of this project is to validate a host-based diagnostic that provides an immune dysregulation score to be compatible with a…

Ended Definitive Contract Awarded Last action

Contract number
75A50124C00038
Awardee
Awarding agency
Obligated
$749,700

Award facts

Opportunity
  • EZBAA22100SOL00003 Solicitation number
Contract value 100% obligated
$749,700.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Competed under SAP · 100 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
New York, NY 10128, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $749,700

About this award

The Office of the Assistant Secretary for Preparedness and Response awarded a $749.7K firm fixed-price contract to Gnomx Corp. (UEI: FJ8GSMZJ6EX1) on September 9, 2024, for development and validation of a host-based diagnostic assay under the GNOMX program's Area of Interest No. 23. The primary objective is to validate a host-based diagnostic capable of generating an immune dysregulation score compatible with point-of-care devices suitable for community setting deployment. The contract is structured as a definitive contract with no set-aside designation and carries an ultimate completion date of October 30, 2026, with performance to be conducted in New York, NY.

The host-based assay is designed to predict the risk of post-discharge deterioration and readmission, supporting the Assistant Secretary for Preparedness and Response's broader mission of strengthening public health emergency preparedness and response capabilities. This development effort aligns with the department's focus on leveraging diagnostic innovations to improve patient outcomes and healthcare delivery in resource-constrained environments, enabling earlier identification of at-risk patients through accessible point-of-care testing platforms.

Description

Gnomx: area of interest no. 23 host-based diagnostics. The overall goal of this project is to validate a host-based diagnostic that provides an immune dysregulation score to be compatible with a point-of-care device for community setting use to strat

Quick answers

Who was awarded contract 75A50124C00038?

75A50124C00038 was awarded to Gnomx Corp. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 9, 2024.

How much is contract 75A50124C00038 worth?

The government has obligated $749,700 on 75A50124C00038.

Was contract 75A50124C00038 competed?

The extent of competition for 75A50124C00038 was competed under sap. The government received 100 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award